You have 9 free searches left this month | for more free features.

City

Basel (2)

Condition

Thyroid Cancer, Medullary (2)

Neuroendocrine Tumor GEP Grade 1-3 (1)

Neuroendocrine Tumor of the Lung Grade 1 and 2 (1)

Neuroendocrine Tumor of the Thymus Grade 1 and 2 (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

early phase 1 (1)

phase 1 (1)

Sponsor

University Hospital, Basel, Switzerland (2)

Collaborator

Center for Proton Therapy, Paul Scherrer Institute, Villigen,Switzerland (2)

Krebsforschung Schweiz, Bern, Switzerland (2)

University Hospital Freiburg (2)

University Hospital, Zurich (2)

Intervention

177lu-pp-f11n (2)

sacuitril (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

177lu-pp-f11n

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Thyroid Cancer, Medullary, Neuroendocrine Tumor of the Lung Grade 1 and 2, Neuroendocrine Tumor of the Thymus Grade 1 and 2

Recruiting

Thyroid Cancer, Medullary
+3 more

177Lu-PP-F11N

Basel, Switzerland

University Hospital Basel, Clinic for radiology and nuclear medi

May 23, 2022

Thyroid Cancer, Medullary Trial in Basel (177Lu-PP-F11N, Sacuitril)

Completed

Thyroid Cancer, Medullary

177Lu-PP-F11N
Sacuitril

Basel, Switzerland

University Hospital Basel, Clinic for radiology and nuclear medi

Feb 9, 2022